Are prophylactic antibiotics necessary for urodynamic study?  by Gürbüz, Cenk et al.
Kaohsiung Journal of Medical Sciences (2013) 29, 325e329Available online at www.sciencedirect.com
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLE
Are prophylactic antibiotics necessary for urodynamic
study?Cenk Gu¨rbu¨z*, Bayram Gu¨ner, Go¨khan Atıs‚, Lu¨tfi Canat, Turhan Cas‚kurluDepartment of 2nd Urology, Istanbul Goztepe Training Hospital, Istanbul, Turkey
Received 18 July 2011; accepted 24 November 2011
Available online 23 December 2012KEYWORDS
Prophylactic
antibiotics;
Urinary tract
infection;
Urodynamics* Corresponding author. Kısıklı maha
E-mail address: gurbuzcenk@yahoo
1607-551X/$36 Copyright ª 2012, Kao
http://dx.doi.org/10.1016/j.kjms.201Abstract The aim of this study was to assess the efficacy of prophylactic fosfomycin tro-
methamine (FT) and ciprofloxacin in preventing bacteriuria caused by urodynamic studies
(UDS). A total of 426 adult patients presenting for UDS were enrolled the study. A midstream
urine sample was taken 72 hours before and 5 days after the procedure. All patients underwent
a standard UDS. The 411 patients who had sterile urine before intervention were included in
the study. Patients were randomized into three groups. Group1 received no prophylaxis
(nZ 133), Group 2 (nZ 141) received oral ciprofloxacin (500 mg) 1 hour before the procedure,
and Group 3 (n Z 137) received a single dose of FT approximately 12 hours before the proce-
dure. Bacteriuria was evaluated for each group. Bacteriuria was detected in 3 (2.3%), 6 (4.3%)
and 3 patients (1.6%) in Group 1, Group 2, and Group 3, respectively. The most common iden-
tified microorganism was Escherichia coli (E coli) in 6 patients (50%). Among the E coli group,
extended spectrum beta-lactamase producing E coli was seen in 2 patients (33.3%). Univariate
analysis demonstrated that a history of urogenital operation (p < 0.01) and female gender
(p < 0.01) were significant risk factors for bacteriuria. On multiple logistic regression analysis,
the past urogenital operation history was the only significant independent risk factor for signif-
icant bacteriuria after UDS (OR Z 14, 95% CI Z 1.82e23.8, p Z 0.01). The prevalence of
bacteriuria after UDS was relatively low in the current study population. Therefore, for most
patients, it may be unnecessary to use preventive prophylactic antibiotics. However, our
results suggest that in patients with a previous history of urologic surgery, the risk for signifi-
cant bacteriuria is increased and the use of prophylaxis should be considered.
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Urodynamic studies (UDS) are generally accepted as the
standard diagnostic tool in the evaluation of patients with
bladder outlet obstruction, urinary incontinence and
neurogenic bladder [1e3]. However, one of the important
risks of the investigation which involves invasive filling and
flow cystometry is that of developing a urinary tract
infection (UTI). The rate of UTI after urodynamics ranges
from 1% to 30% [4e6]. These studies did not screen and
treat any pre-existing UTI at the time of the investigation
and they only reported an overall UTI prevalence after
urodynamic investigation. Without well-documented data
of the urodynamic study attributed UTI prevalence, it is
difficult to determine the necessity and the value of anti-
biotic prophylaxis before urodynamic investigation.
The use of prophylactic antibiotics before or immedi-
ately after UDS is controversial [7,8]. Some studies do not
support routine prophylaxis, because there is no significant
improvement in the overall prevalence of the UTI after
urodynamic investigation [9,10], whereas other studies
suggest prophylaxis is useful [11,12].The aim of this study
was to assess the effectiveness of antibiotic prophylaxis in
preventing bacteriuria in patients undergoing urodynamic
testing.
Methods
In this prospective study, a total of 426 adult patients who
underwent a urodynamic study for urinary incontinence and
lower urinary tract symptoms, were evaluated. Patients
were informed in detail about the procedure and written
consent was obtained. The Institutional Review Board
approved the study protocol. All patients were evaluated
for UTI before the procedure and only patients with
a negative urine culture were considered eligible to take
part in the study. Urine samples were considered to show
a positive culture when 105 colony forming units per mL
(cfu/mL) of a single species were isolated. Exclusion
criteria included a history of urinary tract infection or
antibiotic usage, or urethral instrumentation within the
preceding month, pregnancy, allergy to fosfomycin tro-
methamine (FT) and ciprofloxacin, intermittent self cath-
eterization, long term catheterization in the last 3 months
and risk of endocarditis. All patients underwent a free
uroflow study, cystometry, and a pressure-flow study.
Standard aseptic methods of catheterization were used. All
UDS were performed using a DYNO (AYMED Medical
Measurement System, Istanbul, Turkey).
First, clean-catch midstream urine (MSU) specimens of
the patients involved in the study were obtained 72 hours
before the procedure. A standard UDS was then performed.
A second clean-catch MSU specimen was obtained 5 to 7
days after urodynamic testing. Patients were given detailed
instructions by a nurse about urine collection. Urine spec-
imens were inoculated on to 5% sheep blood agar and
MacConkey agar and identified by standard laboratory
methods for biotyping.
The patients were randomly assigned into three groups.
Group1 received no prophylaxis. Group 2 received cipro-
floxacin (500 mg oral tablets) 1 hour before the procedure.Group 3 received a single dose of FT approximately 12 hours
before the procedure.
The urinary flow rate was initially measured and patients
emptied their bladder. After adequate lubrication with
a sterile lubricating gel, a simultaneously filling and pres-
sure measuring disposable dualelumen catheter (8F;
AYMED Medical Measurement System, Istanbul, Turkey)
mounted with a microtip sensor was placed under strictly
sterile conditions. An 10F Disposable catheter (AYMED
Medical Measurement System) was used for recording rectal
pressure. The proximal extension of each tube was filled
with sterile normal saline. These proximal tubes were
regularly replaced at the end of the study to minimize the
chances of cross-infection, as suggested by the manufac-
turer. During cystometry (AYMED, Istanbul, Turkey) the
bladder was filled with physiological saline at room
temperature at a filling rate of 50 mL/min.
Before leaving the clinic, patients were made aware of
the possibility of irritative symptoms and the risk of lower
UTI. They were advised on 2e3 L of daily fluid intake,
unless they had no significant residual urine, and were
requested to report their body temperature, measured by
a thermometer, twice a day. The patients were asked to
return for a follow-up visit 5e7 days after the procedure.
They were also advised to return immediately if they had
a complication, such as a high fever (>38oC), chills, or
irritating lower urinary tract symptoms lasting >3 days. A
midstream urine culture was obtained from each patient on
day 5 or 7 after UDS.
The main outcome was to assess bacteriuria by culture
of catheterized urine collected immediately before urody-
namic evaluation and a clean-catch midstream specimen
collected 5 to 7 days after evaluation.
Statistical methods
The Chi-square test was used to compare the categorical
variables and Student t test and Mann Whitney U test were
used to compare continuous variables. Multiple logistic
regression analysis was used to adjust for covariates that
were found to be significant in the univariate analyses and
to identify risk factors that were independently associated
with significant bacteriuria after UDS. The level of statis-
tical significance was defined as p < 0.05.
Results
A total of 426 patients were referred to the UDS between
July 2009 and October 2010. Fifteen patients (3.5%) who
had bacteriuria on the initial urine culture were not
included in the study. The remaining 411 patients who had
sterile urine before intervention were included in the
study. Of the 411 patients, 133 were not given antibiotics
before or after the procedure, 141 were given ciprofloxacin
(500 mg oral tablets) 1 hour before the procedure and 137
were given a single dose FT approximately 12 hours before
the procedure.
In 12 patients (2. 9%), significant bacteriuria was iden-
tified after UDS. In 6/12 (50%) patients, MSU specimens with
significant bacteriuria yielded E coli, in 3/12 (25%) patients,
specimens yielded E faecalis, and 3/12 (25%) patients,
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extended spectrum beta-lactamase producing E coli was
seen in two patients (33.3%). Bacteriuria was detected in
three patients (2.3%), six patients (4.3%) and three patients
(1.6%) in Group 1, Group 2 and Group 3, respectively.
Five patients (3.5%) in Group 2 reported adverse events
such as skin rash (1), gastric (3), and headache (1). No
adverse event due to antibiotic application was reported in
Group 3.
The final diagnoses were stress urinary incontinence
(10.9%), detrusor over activity (19.2%), mixed urinary
incontinence (44.1%), obstruction (11%) and normal studies
(14.8%) in the study group. No relationship was found
between the urodynamic diagnosis and significant bacteri-
uria after UDS. The patient characteristics with and without
significant bacteriuria were compared in Table 1. The
numbers of patients with urogenital surgery history were as
follows: urethral stricture (n Z 10), ureteroscopic litho-
tripsy (nZ 24), continence surgery (nZ 14) and have long-
term urethral catheterization or instrumentation (n Z 8).
Previous urogenital operation and female gender were
found to be statistically important risk factors for bacteri-
uria after UDS. Multiple logistic regression analysis was
performed with the use of the following two covariates.
Past urogenital operation history was the only significant
independent risk factor for significant bacteriuria after UDS
(OR Z 14, 95% CI Z 1.82e23.8, p Z 0.01).Discussion
UDS has been recommended as a routine procedure to
confirm voiding dysfunction in both men and women,
especially before any surgical intervention [13,14]. The
most commonly assessed morbidity factor in patientsTable 1 Comparison of characteristics between patients
with and without significant bacteriuria after UDS.
Characteristic With
significant
bacteriuria
Without
significant
bacteriuria
P
Age 60  12.86 52.56  16 0.08
Sex
Female 12 261 0.01
Male 0 138
Urodynamic findings
Normal 1 60 0.402
Abnormal 11 339
Prophylaxis
No 3 130 0.727
Ciprofloxacin 6 135 0.375
Fosfomycin 3 134 0.998
Diabetes Mellitus
Yes 2 68 0.963
No 10 331
Previous urogenital operation
Yes 10 46 0.01
No 2 353undergoing UDS is the development of UTI. The rate of
bacteriuria reported after UDS ranges from 4% to 9%
[10e12,15]. The upper limits of those ranges represent
significant potential morbidity, inducing many clinicians
giving prophylactic antibiotics. Approaches vary consider-
ably in the choice of antimicrobial agents and routes of
administration. There is no consensus on antibiotic
prophylaxis for urodynamic investigation. Some studies do
not support routine prophylaxis, because there is no
significant improvement in the overall prevalence of UTI
after urodynamic investigation, whereas other studies
suggest prophylaxis is useful [9,10].
Worldwide, quinolone resistance rates among Gram-
negative bacilli are rising rapidly [16]. The Turkish Urinary
Tract Infection Study Group recommended that
fluoroquinolone-sparing agents, such as nitrofurantoin and
fosfomycin, should be evaluated as alternative therapies by
further clinical efficacy and safety studies [17]. Treatment
with a single dose of fosfomycin is as effective as the
standard course of treatment of urinary tract infection and
may be preferable due to its simpler administration [18,19].
FT took its place in the treatment of uncomplicated UTIs
with a high in vitro susceptibility and a lack of cross-
resistance to the other agents [20]. In our knowledge, this
study is the first in literature comparing the effectiveness
of FT to that of ciprofloxacin in detecting the incidence of
bacteriuria after UDS in a non-selected pa Following
a single 3g oral dose, peak urinary concentrations occur
within 4 hours and remain high (>128 mg/L) for 24 to 48
hours, which is sufficient to inhibit most urinary tract
pathogens [17]. Patients who underwent UDS were sched-
uled for the morning, so a single dose of FT was adminis-
tered approximately 12 hours before the procedure for the
patient’s convenience. We did not assess the UTI symptoms
specifically in this study, because the symptoms of UTI are
nonspecific and cannot be readily separated from symp-
toms of urogynecological conditions that necessitate UDS.
Decision analysis to assess the risks and benefits of
antibiotic prophylaxis in preventing UTI in women under-
going urodynamic testing was done by Lowder et al. They
decided that when UTI occurred after urodynamics in >10%
of patients, it was more favorable to use the antibiotic
prophylaxis strategy [21]. Each institution could audit their
UTI rates de novo following UDS and then, after discussions
with microbiologists, draw up a policy for antibiotic
prophylaxis if the UTI rates are high. Ideally, rates >5%
should prompt an infection control review. The choice of
prophylactic antibiotics is preferably based on local sensi-
tivities and discussions with a microbiologist. Most clini-
cians would prefer to give prophylactic antibiotics to high
risk groups, like those with renal scarring, recurrent UTIs,
voiding difficulties, prosthetic heart valves, etc. In the
current study, patients with a risk of endocarditis and
prosthetic heart valves were excluded from this study and
the frequency of bacteriuria in the post UDS urine cultures
were recorded as 2.9% overall, and 2.3%, 4.3% and 1.6% in
Group 1, Group 2 and Group 3, respectively.
The significance of asymptomatic bacteriuria has been
studied in various high risk groups, like children and people
with neurogenic bladder. The evidence from these studies
suggests that no antibiotic cover is necessary unless there
are co-existent risk factors like vesicoureteric reflux
328 C. Gu¨rbu¨z et al.[22,23]. The incidences of bacteremia after UDS were
evaluated by Onur et al. [24]; bacteremia was detected in
7% in their study group e half of these subjects (3.5% of the
study group) revealed positive urine cultures, despite the
initial negative urine culture. No infectious complications
were found in the follow up despite the relatively high
incidence of bacteremia (7%) reported in their study. No
symptoms suggested the complicated UTI reported in the
current study, and blood culture was not indicated.
Poor bladder emptying is thought to predispose to UTI.
An association between significant bacteriuria and
abnormal cystometry findings has been reported [25], while
in other literature, difference was found in the urodynamic
data between patients with and without bacteriuria
[26,27]. In the present study, we did not find a relationship
between the urodynamic parameters and significant
bacteriuria, as well as urodynamic diagnosis after UDS.
On the basis of our findings, the small increase in the
prevalence of bacteriuria after urodynamic investigation
does not seem to justify routine antibiotic prophylaxis. The
use of antibiotic prophylaxis generates concern about the
emergence of resistant organisms. Because the overall rate
of bacteriuria after UDS was so low, an argument could be
made that antibiotic prophylaxis was not beneficial.
However, the present study showed that a relatively lower
frequency of bacteriuria occurs with fosfomycin than with
ciprofloxacin. It seems to be rational to administer FT as
a first choice of prophylaxis after the UDS in patients at high
risk.
In an attempt to identify associated risk factors for the
development of significant bacteriuria, we found that
patients with a past history of urologic surgery and female
gender had a higher risk of developing significant bacterial
growth. Urologic surgeries or procedures obtained from
patient reported data; including urethral dilatation for
urethral stricture, ureteroscopic lithotripsy, continence
surgery, have long-term urethral catheterization or instru-
mentation were in common. Following multiple regression
analysis, a past history of urologic surgery was found to be
the significant independent factor.
All of the infected patients were female in our study. It
has been reported that bacteriuria is more common among
women than men, probably due to the proximity of the
female urethra to the anus, its short length and its termi-
nation beneath the labia [28]. It may also result from
contamination during or after collection of urine. In the
current study, all patients were well informed for sampling
by clinical nurse to avoid contamination. Sexual intercourse
might have aggravated bacteriuria in females. It would
have been of great interest if we had been able to query
the patients on the frequency and intensity of coitus for the
period immediately after the urodynamic studies to the
time that the post-procedure urine studies were obtained.
These were not recorded.
There is inconsistency in the literature regarding the
best time to collect urine before and after UDS. In the
present study, MSU was obtained 3 days before UDS. Urine
was evaluated with conventional techniques and
a minimum of 2 days was required to report urine sterility.
In the present study, a clean-catch midstream specimen
was collected 5e7 days after evaluation. The 5e7 day
interval was chosen to increase enrollment. Many patientsreferred to this practice traveled long distances, and we
believed they would consider a more rapid and narrower
time frame after UDS for second cultures to be
inconvenient.
A major limitation of this study is the lack of a placebo
control group. Placebo-controlled, randomized, double-
blinded studies, which include a large number of patients,
are necessary to evaluate whether the prophylaxis is useful
for UDS.
The prevalence of bacteriuria after UDS was relatively
low in our study population. Therefore, for most patients, it
may be unnecessary to use preventive prophylactic antibi-
otics. However, our findings demonstrate that patients with
a history of urologic surgery should be fully advised of the
possibility of urinary infection and use of prophylaxis for
UDS should be considered.Acknowledgments
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